LINGO1 and myeloid sarcoma: LINGO-1 expression is upregulated in MS lesions, and blockade using antagonistic antibodies or genetic deletion results in increased axonal myelination, both in vitro and in vivo, with amelioration of the disease in the EAE model [68].